( in vitro metabolism of APAP and LC-MS/MS
When trained on a specific area, such as the scalp, these rays help to energise and stimulate the bodys natural process for building new proteins and regenerating cells
These include: Nausea and vomiting typically most pronounced during dose escalation and often improving with continued use Diarrhoea or constipation affecting bowel habit regularity Abdominal pain and discomfort ranging from mild cramping to more significant discomfort Dyspepsia and gastro-oesophageal reflux related to delayed gastric emptying Injection site reactions are classified as 'common' (affecting up to 1 in 10 people) and may include redness, itching, bruising, or localised swelling at the subcutaneous injection site
Ada S, Sahin S, Boztepe G, Karaduman A, Klemen F
Pharmacoeconomics 33 , 673689 (2015)
It targets GLP-1, GIP, and adds the Glucagon Receptor into the mix: The Glucagon Element: While GLP-1 and GIP primarily focus on calorie restriction, satiety, and insulin management, glucagon directly influences energy expenditure